School of Medicine
Showing 7,661-7,680 of 12,915 Results
-
Jeff Morgan
Stanford Children'S Health - Biomechanist Technical Supervisor, Orthopaedic Surgery
BioI provide biomechanical expertise for clinical evaluations of patients post injury with the goal of reducing re-injury rates and improving performance. As a sports-focused lab, we specialize in running gait analysis, ACL reconstruction return to sport testing, and other lower extremity injuries. Our primary tool for analysis is 3D motion capture coupled with tri-axial force data which allows us to evaluate a patient's movement and the underlying forces as they complete sport specific tasks.
I manage research studies evaluating the contribution of running mechanics to bone stress injuries and improving patient outcomes after ACL and MPFL reconstruction. -
Nancy Morioka-Douglas, MD, MPH
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests--Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
--Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
--Enhancing physician and staff satisfaction in caring for patients -
Elizabeth Mormino
Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research)
BioDr. Beth Mormino completed a PhD in Neuroscience at UC Berkeley in the laboratory of Dr. William Jagust, where she performed some of the initial studies applying Amyloid PET with the tracer PIB to clinically normal older individuals. This initial work provided evidence that the pathophysiological processes of Alzheimer’s disease begin years before clinical symptoms and are associated with subtle changes to brain regions critical for memory. During her postdoctoral fellowship with Drs. Reisa Sperling and Keith Johnson at Massachusetts General Hospital she used multimodal imaging techniques to understand longitudinal cognitive changes among individuals classified as preclinical AD. In 2017, Dr. Mormino joined the faculty at Stanford University in the department of Neurology and Neurological Sciences. Her research program focuses on combining imaging and genetics to predict cognitive trajectories over time, and the integration of novel PET scans to better understand human aging and neurodegenerative diseases.
-
Martha Morrell, MD
Clinical Professor, Adult Neurology
BioDr. Morrell is a Clinical Professor of Neurology at Stanford University since July 2004. Before joining NeuroPace, she was the Caitlin Tynan Doyle Professor of Clinical Neurology at Columbia University and Director of the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital in New York City. Previously she was on the faculty of the Stanford University School of Medicine where she served as Director of the Stanford Comprehensive Epilepsy Center. A graduate of Stanford Medical School, she completed residency training in Neurology at the University of Pennsylvania, as well as fellowship training in EEG and epilepsy.
Dr. Morrell has been actively involved in helping to bring new medical and device therapies to patients with epilepsy. Since 2004, she has been Chief Medical Officer at NeuroPace, a company that developed a responsive neurostimulator for treatment of medically uncontrolled partial seizures. She has authored or coauthored more than 150 publications.
Service to professional societies includes member of the Board of Directors of the American Epilepsy Society, member and Chair of the Board of the Epilepsy Foundation, member of the Council of the American Neurological Association and Chair of the Epilepsy Section of the American Academy of Neurology. She is an elected Ambassador for Epilepsy of the International League Against Epilepsy and received the American Epilepsy Society’s 2007 Service Award for outstanding leadership and service. She is the current President of the American Society for Experimental Neurotherapeutics. -
Arden Morris, MD, MPH, FACS
Robert L. and Mary Ellenburg Professor of Surgery, and Professor, by courtesy, of Health Policy
BioArden M. Morris, MD, MPH is Vice-Chair for Clinical Research, the Robert L. and Mary Ellenburg Professor of Surgery, and by courtesy Professor of Health Policy at the Stanford School of Medicine. She is Director of the S-SPIRE Center, a health services research collaborative to study patient-centered care, clinical optimization, and health care economics. In her own work, Dr. Morris uses quantitative, qualitative, and mixed research methods to focus on quality of and equity in cancer care. To that end, she currently is funded by American Cancer Society and NIH to study access to care, clinical outcomes, and policy related to insurance design. Dr. Morris currently serves on the American Joint Commission on Cancer, the NIH Special Emphasis Panel “Topics in Health Services Research: Big Data, Health Information Technology, and Clinical Informatics,” and as Associate Editor for Surgery at JAMA Network Open.
-
Garret K. Morris, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Morris is a board-certified, fellowship-trained anesthesiologist with a clinical focus on pain medicine. He is also a clinical assistant professor in the Division of Pain Medicine of the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. Dr. Morris has expertise in chronic pain management, inpatient pain management, spine care, and functional restoration.
He treats a wide range of pain conditions including musculoskeletal, neuropathic, visceral and mixed. With each patient in his care, Dr. Morris’ objective is to alleviate suffering using the treatment approach that is most likely to maximize effectiveness and minimize risk. The focus is on using the least invasive interventions possible to improve each individual’s function and quality of life.
To help achieve these goals, Dr. Morris takes a holistic approach encompassing six domains of pain management: pharmacological, interventional, behavioral/psychological, physical rehabilitative, alternative and complementary therapies, and self-management. Often this approach requires a multidisciplinary team of diverse professionals with Dr. Morris overseeing care planning, implementation, and follow-up. This is especially helpful for challenging cases, where a collaborative team-based approach affords greater potential for superior outcomes.
Dr. Morris communicates closely with referring physicians to devise holistic pain management that fits holistically into each patient’s comprehensive care plan.
Dr. Morris has authored articles and reviews in publications including Anesthesiology, Regional Anesthesia and Pain Medicine, American Society for Artificial Organs Journal, Cancer Detection and Prevention, and the Journal of Orthopedics & Sports Physical Therapy. He also has contributed the chapter “Occipital Nerve Block” in the textbook Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Behavioral Approaches published by the American Academy of Pain Medicine. In addition, Dr. Morris has contributed online content on postoperative pain relief to the electronic forum, The Stanford Anesthesia Informatics and Media Lab (AIM).
He has made presentations at conferences including the American Society of Anesthesiology Annual Meeting and the Annual Rochester (New York) Regional Anesthesia Symposium. He also has delivered invited lectures, most recently on interventional techniques for the treatment of spinal disorders as part of the Excellus Blue Cross Blue Shield Project.
Dr. Morris’ honors for clinical practice include awards from Advocate Illinois Masonic Medical Center. He has received recognition for his scholarship from the Dannemiller Memorial Education Foundation and Midwest Anesthesia Resident’s. -
Randall Morris
Professor (Research) of Cardiothoracic Surgery, Emeritus
Current Research and Scholarly InterestsDiscovery, preclinical and clinical development of novel immunosuppressive molecules for prevention or treatment of immune or inflammatory or ischemic injury to cell and organ transplants and for suppression of autoimmune diseases and acute organ injuries including small molecule, monoclonal and biologic classes of therapeutics.
